Recruiting Heart Attack Studies in Homestead
Secukinumab Open Label Roll-over Extension Protocol
The purpose of this study is to assess long term safety in participants who have completed a Novartis trial with secukinumab, have been judged by the investigator to benefit from continued treatment w...
A Phase 2a Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
The main objective is to assess the safety and tolerability of inebilizumab in adult participants with active and refractory systemic lupus erythematosus (SLE) with nephritis (Subprotocol A) and to as...
About Heart Attack Clinical Trials in Homestead
A heart attack (myocardial infarction) occurs when blood flow to part of the heart muscle is blocked, usually by a blood clot. It is a medical emergency requiring immediate treatment. Long-term management includes medications, lifestyle changes, and cardiac rehabilitation.
There are currently 2 heart attack clinical trials recruiting participants in Homestead, FLORIDA. These studies are seeking a combined 813 participants. Research is being sponsored by Novartis Pharmaceuticals, Amgen. Clinical trial participation is free and participants receive study-related medical care at no cost.
Heart Attack Clinical Trials in Homestead — FAQ
Are there heart attack clinical trials in Homestead?
Yes, there are 2 heart attack clinical trials currently recruiting in Homestead, FLORIDA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Homestead?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Homestead research site will contact you about next steps.
Are clinical trials in Homestead free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Homestead studies also compensate for your time and travel.
What heart attack treatments are being tested?
The 2 active trials in Homestead are testing new therapies including novel drugs, biologics, and treatment approaches for heart attack.
Data updated March 2, 2026 from ClinicalTrials.gov